The Effect of Moxonidine on Blood Pressure and Regression of Early Target Organ Damage in Young Subjects With Abdominal Obesity and Hypertension

NCT01360710 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Abdominal Obesity
Hypertension

Interventions

DRUG: Moxonidine
DRUG: Irbesartan

Sponsor

Baker Heart and Diabetes Institute